Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 6, 2013, Pages 960-970

  Tang, Xiaoju ^a   Liu, Xiaojing J ^a   Tian, Cuijie ^a   Su, Qiaoli ^a   Lei, Yi ^a   Wu, Qingbo ^a   He, Yangyan ^a   Whitsett, Jeffrey A ^b   Luo, Fengming ^a  

^a SICHUAN UNIVERSITY   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Foxa2; Leukotriene; Mucous metaplasia; Th2 inflammation

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARG2 PROTEIN; CYCLOOXYGENASE 2; EOTAXIN 2; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; MONTELUKAST; MUCIN 5AC; PROSTAGLANDIN E2; PROSTAGLANDIN H2; PROTEIN; SPDEF PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GOBLET CELL; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG LAVAGE; LUNG PARENCHYMA; METAPLASIA; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TH2 CELL;

ACETATES; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; CYSTEINE; DISEASE MODELS, ANIMAL; EOSINOPHILS; GOBLET CELLS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; INFLAMMATION MEDIATORS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; METAPLASIA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PNEUMONIA; QUINOLINES; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84890101527     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0122OC     Document Type: Article

References (36)

1. Roongapinun S, Oh SY, Wu F, Panthong A, Zheng T, Zhu Z. Role of SHIP-1 in the adaptive immune responses to aeroallergen in the airway. PLoS ONE 2010;5:e14174.
2. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38:872-897.
3. Chen G, Wan H, Luo F, Zhang L, Xu Y, Lewkowich I, Wills-Karp M, Whitsett JA. Foxa2 programs Th2 cell-mediated innate immunity in the developing lung. J Immunol 2010;184:6133-6141.
4. Maeda Y, Chen G, Xu Y, Haitchi HM, Du L, Keiser AR, Howarth PH, Davies DE, Holgate ST, Whitsett JA. Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation. Am J Respir Crit Care Med 2011;184:421-429.
5. Okunishi K, Peters-Golden M. Leukotrienes and airway inflammation. Biochim Biophys Acta 2011;1810:1096-1102.
6. Ogawa Y, Calhoun WJ. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 2006;118:789-800.
7. Montuschi P, Peters-Golden ML. Leukotriene modifiers for asthma treatment. Clin Exp Allergy 2010;40:1732-1741.
8. Dahlén SE. Pharmacological characterization of leukotriene receptors. Am J Respir Crit Care Med 2000;161:S41-S45.
9. Toda A, Yokomizo T, Shimizu T. Leukotriene B4 receptors. Prostaglandins Other Lipid Mediat 2002;68-69:575-585.
10. Jiang Y, Kanaoka Y, Feng C, Nocka K, Rao S, Boyce JA. Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol 2006;177:2755-2759.
11. Jackson SE, Holloway JW, Warner JA, Sampson AP. Interleukin-13, but not indomethacin, increases cysteinyl-leukotriene synthesis in human lung macrophages. J Allergy (Cairo) 2012;2012:348741.
12. Kim DC, Hsu FI, Barrett NA, Friend DS, Grenningloh R, Ho IC, Al-Garawi A, Lora JM, Lam BK, Austen KF, et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol 2006;176:4440-4448.
13. Chibana K, Ishii Y, Asakura T, Fukuda T. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 2003;170:4290-4295.
14. Wan H, Xu Y, Ikegami M, Stahlman MT, Kaestner KH, Ang SL, Whitsett JA. Foxa2 is required for transition to air breathing at birth. Proc Natl Acad Sci USA 2004;101:14449-14454.
15. Andersson CK, Claesson HE, Rydell-Törmänen K, Swedmark S, Hällgren A, Erjefält JS. Mice lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. Am J Respir Cell Mol Biol 2008;39:648-656.
16. Bhattacharjee A, Mulya A, Pal S, Roy B, Feldman GM, Cathcart MK. Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity. J Immunol 2010;185:5211-5224.
17. Profita M, Sala A, Bonanno A, Siena L, Ferraro M, Di Giorgi R, Montalbano AM, Albano GD, Gagliardo R, Gjomarkaj M. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. J Pharmacol Exp Ther 2008;325:1024-1030.
18. Meliton AY, Munoz NM, Leff AR. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion. J Allergy Clin Immunol 2007;120:1316-1323.
19. Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108-116.
20. Cardoso WV. Transcription factors and pattern formation in the developing lung. Am J Physiol 1995;269:L429-L442.
21. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, Stahlman MT, Fulkerson PC, Rothenberg ME, Whitsett JA. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004;131:953-964.
22. Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang SL, Wert S, Stahlman MT, Whitsett JA. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem 2005;280:13809-13816.
23. Hallstrand TS, Henderson WR Jr. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 2010;10:60-66.
24. Elias JA, Lee CG, Zheng T, Shim Y, Zhu Z. Interleukin-13 and leukotrienes: an intersection of pathogenetic schema. Am J Respir Cell Mol Biol 2003;28:401-404.
25. Faith A, Fernandez MH, Caulfield J, Loke TK, Corrigan C, O'Connor B, Lee TH, Hawrylowicz CM. Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophagecolony stimulating factor. Allergy 2008;63:168-175.
26. Thivierge M, Stanková J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 2001;167:2855-2860.
27. Finkelman FD, Hogan SP, Hershey G K K, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010;184:1663-1674.
28. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202:175-190.
29. Barnes PJ. Current and future therapies for airway mucus hypersecretion. Novartis Found Symp 2002;248:237-253, 277-282.
30. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 2003;9:21-27.
31. Vargaftig BB, Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 2003;28:410-419.
32. + T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol 2012;13:347-353.
33. Harizi H, Gualde N. Eicosanoids: an emerging role in dendritic cell biology. Arch Immunol Ther Exp (Warsz) 2004;52:1-5.
34. Bousquet J, Demoly P, Humbert M. Montelukast in guidelines and beyond. Adv Ther 2009;26:575-587.
35. Schlick W, Pohl W, Pfeiffer KP, Aigner K, Forche G, Kneussl M, Zwick H. Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR openlabel, real-world, observational study. Curr Med Res Opin 2010;26:561-570.
36. Park SW, Verhaeghe C, Nguyenvu LT, Barbeau R, Eisley CJ, Nakagami Y, Huang X, Woodruff PG, Fahy JV, Erle DJ. Distinct roles of Foxa2 and Foxa3 in allergic airway disease and asthma. Am J Respir Crit Care Med 2009;180:603-610.